ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025
Homocysteine: Canary in the Coal Mine or Hidden Threat? A Biochemical Study on the Role of Plasma Thiols.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Distinct plasma proteome signature at 3 months post-COVID-19 infection irrespective of post-COVID condition.Scientific reports · 2026Article
- Machine learning model based on routine blood and biochemical parameters for early diagnosis of diabetic kidney disease.Frontiers in endocrinology · 2026Article
- Homocysteine: Canary in the Coal Mine or Hidden Threat? A Biochemical Study on the Role of Plasma Thiols.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Homocysteinemia is routinely measured as a biomarker of cardiovascular risk, but its pathogenic role remains controversial because it is unclear whether-and how-interventions to lower homocysteine levels provide real benefit. In the present original study, we analyzed in detail the effects of oxidative stress, thiol-disulfide exchange reactions, and plasma thiol levels on homocysteinemia. We conducted a clinical study in a group of healthy, homogeneous individuals (n = 62) in which the different redox forms of plasma thiols and several biomarkers of oxidative stress were determined. Homocysteine was characterized by the fact that it was almost completely present as mixed protein disulfide (about 80%-85%). A strong inverse correlation was found between total homocysteine and glutathione concentrations, whereas no correlation was found between homocysteine and oxidative stress markers. The observation that oxidative stress does not affect total homocysteine levels in plasma was confirmed by in vitro treatments of human blood with a special device that allows slow delivery of oxidants. Experiments with cultured cells showed that they can release glutathione in large quantities with different kinetics over time. In addition, a strong inverse correlation between GSH and total homocysteine has been demonstrated in the plasma of humans of different ages and in mammalian species. All these data support the hypothesis that GSH, once released from cells, can trigger a series of thiol-disulfide exchange reactions leading to the cleavage of protein-bound homocysteine and the increase of free homocysteine, thus promoting its excretion. It can therefore be concluded that homocysteinemia can be regulated by the release of GSH from cells and that, consequently, total homocysteine in plasma can be considered a biomarker of cardiovascular risk without necessarily having a direct causal role. The specificity of this process must be taken into account when investigating the pathogenetic role of homocysteine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.